Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioceres Crop Solutions (BIOX) Invested Capital (2016 - 2026)

Bioceres Crop Solutions' Invested Capital history spans 11 years, with the latest figure at $67.7 million for Q1 2026.

  • On a quarterly basis, Invested Capital changed N/A to $67.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $67.7 million, a N/A change, with the full-year FY2025 number at $527.8 million, down 14.6% from a year prior.
  • Invested Capital hit $67.7 million in Q1 2026 for Bioceres Crop Solutions, down from $527.8 million in the prior quarter.
  • Over the last five years, Invested Capital for BIOX hit a ceiling of $618.0 million in Q2 2024 and a floor of $67.7 million in Q1 2026.
  • Historically, Invested Capital has averaged $424.3 million across 5 years, with a median of $527.8 million in 2025.
  • Biggest five-year swings in Invested Capital: soared 75.86% in 2023 and later dropped 14.6% in 2025.
  • Tracing BIOX's Invested Capital over 5 years: stood at $329.2 million in 2022, then skyrocketed by 75.86% to $579.0 million in 2023, then rose by 6.73% to $618.0 million in 2024, then dropped by 14.6% to $527.8 million in 2025, then crashed by 87.17% to $67.7 million in 2026.
  • Business Quant data shows Invested Capital for BIOX at $67.7 million in Q1 2026, $527.8 million in Q2 2025, and $618.0 million in Q2 2024.